According to Precedence Research, the global point of care testing (POCT) market size will grow from USD 44.48 billion in 2025 to nearly USD 125.33 billion by 2034, with a healthy CAGR of 12.20% from ...

For nearly two decades, offensive security has centered around the same basic ritual: schedule an annual or quarterly penetration test, brace for the findings, remediate what you can, and then repeat ...

cDepartment of Molecular Medicine, University of Padua, Padua, Italy ...

Objective: Evidence on the utility of CYP2C19 point-of-care (POC) testing to guide antiplatelet therapy selection in patients with acute coronary syndrome (ACS) or stable coronary artery disease (CAD) ...

dEvaluation and Implementation Science Unit, Centre for Health Policy, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VA, Australia eFirst Nations Cancer & ...

Point-of-care testing for group A beta-hemolytic Streptococcus (Strep A) significantly reduced antibiotic prescriptions in children and adults with signs of pharyngitis, even when used as the sole ...

The Food and Drug Administration (FDA), in collaboration with the National Institutes of Health (NIH), hosted a workshop focused on reducing animal testing. The event builds on the recent release of ...

This pilot study evaluates a newly developed point-of-care (PoC) device designed to measure bilirubin levels in human blood serum using a microfluidic cartridge and optoelectronic sensing module.

NEW YORK – Last year, a 15-year research and development slog finally culminated in regulatory approval and instrument sales for QuidelOrtho's Savanna molecular diagnostics system. But in a twist ...

Chronic kidney disease (CKD) affects over 800 million people globally and is often diagnosed too late for effective intervention. Early detection depends on accurate measurement of biomarkers such as ...